Brief: Xspray Pharma Has Carried Out A Directed Share Issue Raising Gross Proceeds Of Approximately SEK 122 Mln
Dec 5 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST :
* XSPRAY PHARMA HAS CARRIED OUT A DIRECTED SHARE ISSUE
RAISING
GROSS PROCEEDS OF APPROXIMATELY SEK 122 MILLION
Source text for Eikon: ID:nWkr7g3kpr
Further company coverage: XSPRAY.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003